Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of AUROBINDO PHARMA. For more details, see the AUROBINDO PHARMA quarterly results and AUROBINDO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.0 |
No. of shares | m | 585.94 |
1 Week | % | -0.4 |
1 Month | % | 6.1 |
1 Year | % | 83.5 |
52 week H/L | Rs | 1,177.0/581.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AUROBINDO PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 830 | 838 | 1,023 | 1,064 | 715 | |
Low | Rs | 527 | 281 | 333 | 584 | 397 | |
Sales per share (Unadj.) | Rs | 333.9 | 394.2 | 422.8 | 400.3 | 424.2 | |
Earnings per share (Unadj.) | Rs | 40.4 | 48.5 | 91.0 | 45.2 | 32.9 | |
Diluted earnings per share | Rs | 40.4 | 48.5 | 91.0 | 45.2 | 32.9 | |
Cash flow per share (Unadj.) | Rs | 51.8 | 65.0 | 109.0 | 64.4 | 54.1 | |
Dividends per share (Unadj.) | Rs | 2.50 | 3.00 | 4.00 | 9.00 | 3.00 | |
Adj. dividends per share | Rs | 2.50 | 3.00 | 4.00 | 9.00 | 3.00 | |
Avg Dividend yield | % | 0.4 | 0.5 | 0.6 | 1.1 | 0.5 | |
Book value per share (Unadj.) | Rs | 237.1 | 287.1 | 374.3 | 419.4 | 458.1 | |
Adj. book value per share | Rs | 237.1 | 287.1 | 374.3 | 419.4 | 458.1 | |
Shares outstanding (eoy) | m | 585.89 | 585.94 | 585.94 | 585.94 | 585.94 | |
Price / Sales ratio | x | 2.0 | 1.4 | 1.6 | 2.1 | 1.3 | |
Avg P/E ratio | x | 16.8 | 11.5 | 7.5 | 18.2 | 16.9 | |
P/CF ratio (eoy) | x | 13.1 | 8.6 | 6.2 | 12.8 | 10.3 | |
Price / Book Value ratio | x | 2.9 | 1.9 | 1.8 | 2.0 | 1.2 | |
Dividend payout | % | 6.2 | 6.2 | 4.4 | 19.9 | 9.1 | |
Avg Mkt Cap | Rs m | 397,541 | 327,877 | 397,398 | 482,799 | 325,753 | |
Total wages/salary | Rs m | 25,849 | 32,192 | 35,350 | 34,509 | 35,223 |
AUROBINDO PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 195,636 | 230,985 | 247,746 | 234,555 | 248,554 | |
Other income | Rs m | 1,553 | 1,919 | 3,809 | 3,226 | 2,906 | |
Total revenues | Rs m | 197,189 | 232,904 | 251,555 | 237,781 | 251,460 | |
Gross profit | Rs m | 38,666 | 48,230 | 80,926 | 42,253 | 37,070 | |
Depreciation | Rs m | 6,680 | 9,667 | 10,554 | 11,265 | 12,446 | |
Interest | Rs m | 2,626 | 3,051 | 745 | 486 | 1,405 | |
Profit before tax | Rs m | 30,914 | 37,430 | 73,436 | 33,727 | 26,125 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 7,269 | 8,994 | 20,098 | 7,256 | 6,849 | |
Profit after tax | Rs m | 23,645 | 28,437 | 53,338 | 26,471 | 19,277 | |
Gross profit margin | % | 19.8 | 20.9 | 32.7 | 18.0 | 14.9 | |
Effective tax rate | % | 23.5 | 24.0 | 27.4 | 21.5 | 26.2 | |
Net profit margin | % | 12.1 | 12.3 | 21.5 | 11.3 | 7.8 |
AUROBINDO PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 153,323 | 164,125 | 197,399 | 180,436 | 214,599 | |
Current liabilities | Rs m | 120,206 | 113,846 | 106,651 | 81,560 | 114,938 | |
Net working cap to sales | % | 16.9 | 21.8 | 36.6 | 42.2 | 40.1 | |
Current ratio | x | 1.3 | 1.4 | 1.9 | 2.2 | 1.9 | |
Inventory Days | Days | 15 | 15 | 19 | 25 | 21 | |
Debtors Days | Days | 64 | 68 | 52 | 62 | 66 | |
Net fixed assets | Rs m | 109,388 | 123,520 | 135,778 | 155,104 | 176,668 | |
Share capital | Rs m | 586 | 586 | 586 | 586 | 586 | |
"Free" reserves | Rs m | 138,321 | 167,661 | 218,713 | 245,174 | 267,813 | |
Net worth | Rs m | 138,907 | 168,247 | 219,299 | 245,760 | 268,399 | |
Long term debt | Rs m | 1,800 | 0 | 1,685 | 2,492 | 6,190 | |
Total assets | Rs m | 262,711 | 287,645 | 334,013 | 336,331 | 392,125 | |
Interest coverage | x | 12.8 | 13.3 | 99.6 | 70.3 | 19.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | |
Return on assets | % | 10.0 | 10.9 | 16.2 | 8.0 | 5.3 | |
Return on equity | % | 17.0 | 16.9 | 24.3 | 10.8 | 7.2 | |
Return on capital | % | 23.8 | 24.1 | 33.6 | 13.8 | 10.0 | |
Exports to sales | % | 49.6 | 46.4 | 53.8 | 31.1 | 33.7 | |
Imports to sales | % | 18.8 | 15.1 | 16.4 | 11.9 | 15.3 | |
Exports (fob) | Rs m | 97,091 | 107,126 | 133,248 | 72,862 | 83,703 | |
Imports (cif) | Rs m | 36,741 | 34,902 | 40,615 | 27,965 | 38,060 | |
Fx inflow | Rs m | 97,316 | 107,445 | 133,447 | 77,245 | 85,483 | |
Fx outflow | Rs m | 40,589 | 38,991 | 44,946 | 31,524 | 41,447 | |
Net fx | Rs m | 56,727 | 68,454 | 88,501 | 45,721 | 44,036 |
AUROBINDO PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 16,510 | 43,813 | 33,291 | 50,165 | 23,868 | |
From Investments | Rs m | -29,026 | -15,676 | 5,987 | -32,116 | -39,778 | |
From Financial Activity | Rs m | 19,191 | -19,472 | -13,649 | -29,693 | 18,144 | |
Net Cashflow | Rs m | 6,656 | 8,712 | 25,831 | -11,674 | 2,298 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: K Ragunathan | COMP SEC: B Adi Reddy | YEAR OF INC: 1986 | BSE CODE: 524804 | FV (Rs): 1 | DIV YIELD (%): 0.3 |
Read: AUROBINDO PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare AUROBINDO PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.